234 related articles for article (PubMed ID: 12594811)
1. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma.
Kimura F; Seifert HH; Florl AR; Santourlidis S; Steinhoff C; Swiatkowski S; Mahotka C; Gerharz CD; Schulz WA
Int J Cancer; 2003 May; 104(5):568-78. PubMed ID: 12594811
[TBL] [Abstract][Full Text] [Related]
2. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
3. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation, mRNA expression of goat tumor‑associated genes and mRNA expression of DNA methyltransferase in enzootic nasal tumors.
Quan Z; Ye N; Hao Z; Wen C; Liao H; Zhang M; Luo L; Cao S; Wen X; Wu R; Yan Q
Mol Med Rep; 2015 Oct; 12(4):6275-85. PubMed ID: 26252527
[TBL] [Abstract][Full Text] [Related]
6. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus.
Zhu X; Liang J; Li F; Yang Y; Xiang L; Xu J
Int J Dermatol; 2011 Jun; 50(6):697-704. PubMed ID: 21595664
[TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
8. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
[TBL] [Abstract][Full Text] [Related]
9. An association between overexpression of DNA methyltransferase 3B4 and clear cell renal cell carcinoma.
Liu Y; Sun L; Fong P; Yang J; Zhang Z; Yin S; Jiang S; Liu X; Ju H; Huang L; Bai J; Gong K; Yan S; Zhang C; Shao G
Oncotarget; 2017 Mar; 8(12):19712-19722. PubMed ID: 28160561
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes DNA methyltransferase I protein and maintains DNA methylation.
Sun L; Zhao H; Xu Z; Liu Q; Liang Y; Wang L; Cai X; Zhang L; Hu L; Wang G; Zha X
Cell Signal; 2007 Nov; 19(11):2255-63. PubMed ID: 17716861
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract][Full Text] [Related]
13. Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer.
Kang MY; Lee BB; Kim YH; Chang DK; Kyu Park S; Chun HK; Song SY; Park J; Kim DH
Int J Cancer; 2007 Nov; 121(10):2192-7. PubMed ID: 17657744
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault I; Tozlu S; Lidereau R; Bièche I
Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
[TBL] [Abstract][Full Text] [Related]
15. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma.
Ping SY; Shen KH; Yu DS
Mol Carcinog; 2013 Jul; 52(7):568-79. PubMed ID: 22392726
[TBL] [Abstract][Full Text] [Related]
17. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation.
Leu YW; Rahmatpanah F; Shi H; Wei SH; Liu JC; Yan PS; Huang TH
Cancer Res; 2003 Oct; 63(19):6110-5. PubMed ID: 14559786
[TBL] [Abstract][Full Text] [Related]
18. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.
James SR; Link PA; Karpf AR
Oncogene; 2006 Nov; 25(52):6975-85. PubMed ID: 16715135
[TBL] [Abstract][Full Text] [Related]
20. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
Huidobro C; Urdinguio RG; Rodríguez RM; Mangas C; Calvanese V; Martínez-Camblor P; Ferrero C; Parra-Blanco A; Rodrigo L; Obaya AJ; Suárez-Fernández L; Astudillo A; Hernando H; Ballestar E; Fernández AF; Fraga MF
Eur J Cancer; 2012 Sep; 48(14):2270-81. PubMed ID: 22244828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
